Ramsay Générale de (GDS) | Stock Overview & Key Data
Ramsay Générale de Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €26.10 on June 6, 2022
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Quarter Income Flow
Dec 31, 2014
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.10B Large-cap | -0.44% | 8.74% | 7.18% | 24.44% | 19.91% | 1.34% | -43.25% | -42.39% | -9.42% | 37.08% | 37.08% | |
|
Emeis S.A
EMEIS
|
2.28B Large-cap | -2.97% | -9.31% | -2.28% | 4.65% | -6.09% | 35.08% | -91.30% | -99.79% | -99.68% | -99.55% | -99.55% |
|
Orpea
ORP
|
2.19B Large-cap | -3.09% | -8.72% | 7.30% | 7.30% | 7.30% | 12.35% | 12.35% | 12.35% | 12.35% | 12.35% | 12.35% |
|
Clariene SE
CLARI
|
1.36B Large-cap | -0.74% | -5.16% | 15.10% | 15.10% | 15.10% | 20.23% | 20.23% | 20.23% | 20.23% | 20.23% | 20.23% |
|
Lna Santé S.A
LNA
|
297.53M Mid-cap | -2.94% | 9.27% | 18.71% | 18.71% | 18.71% | 26.14% | 26.14% | 26.14% | 26.14% | 26.14% | 26.14% |
|
TheraVet S.A
ALVET
|
N/A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -89.74% | -98.11% | -99.02% | -99.02% | -99.02% | -99.02% |
Ownership & Short Interest
Calculate Your Ramsay Générale de Investment Returns
Long-Term Investment Performance Analysis
Ramsay Générale de stock price in Jul 2016 was €12.43, A €1,000.00 lump sum investment in Ramsay Générale de made 9 years ago would be worth approximately €901.05 today, representing a negative return of -9.90%. This translates to an annualized return (CAGR) of -1.05%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is GDS's 52-week high and low?
- In the last 52 weeks, Ramsay Générale de reached a high of €11.55 (on June 1, 2026) and a low of €8.72 (on December 19, 2025).
- What is the market cap and P/E ratio for GDS?
- Curious about Ramsay Générale de's size and valuation? Its market capitalization stands at 1.10B. When it comes to valuation, the P/E ratio (trailing twelve months) is 34.13, and the forward P/E (looking ahead) is N/A.
- Does GDS pay dividends? If so, what's the yield?
- As for dividends, Ramsay Générale de isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Ramsay Générale de's main competitors or similar companies to consider before investing?
When looking at Ramsay Générale de, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Emeis S.A
EMEIS2.28B Healthcare Medical Care Facilities 35.08% -91.30% Orpea
ORP2.19B Healthcare Medical Care Facilities 12.35% 12.35% Clariene SE
CLARI1.36B Healthcare Medical Care Facilities 20.23% 20.23% Lna Santé S.A
LNA297.53M Healthcare Medical Care Facilities 26.14% 26.14% TheraVet S.A
ALVETN/A Healthcare Biotechnology -89.74% -98.11% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Ramsay Générale de Santé S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Ramsay Générale de's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -2.24%, the Debt to Equity ratio from the most recent quarter is 343.06, and its Gross Profit Margin stands at 71.87%.
- What is the recent revenue and earnings growth for GDS?
- Looking at Ramsay Générale de's growth, its revenue over the trailing twelve months (TTM) was €5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.30%, and quarterly earnings saw a YoY growth of -33.60%.
- How much of GDS stock is held by insiders and institutions?
- Wondering who owns Ramsay Générale de stock? Company insiders (like executives and directors) hold about 59.47% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 39.92%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.